In the pharmaceutical industry, computerized systems impacting GxP environments must adhere to strict regulations to ensure product quality and patient safety. A documented inventory is essential for controlling these systems, identifying their GxP impact, and assessing their associated risk levels. This inventory supports regulatory compliance, facilitates audits, and enables strategic planning of systems, contributing to transparency and data integrity.
BLOG
The transportation of psychotropics within the pharmaceutical industry is a complex and highly regulated process due to their potential for abuse and impact on health. These medications require specialized handling and compliance with international and local regulations, including permits and comprehensive tracking of product movement. Key challenges include regulatory compliance, storage conditions, security and traceability, and proper documentation. Best practices encompass real-time monitoring, staff training, security protocols, and risk management. Technology, such as IoT and blockchain, has enhanced transparency in the supply chain, ensuring the efficient distribution of these critical medications.
The COVID-19 pandemic quickly changed our understanding of how the virus spreads, sparking debates on the size of respiratory droplets and social distancing measures. Dr. Anthony Fauci, a key figure in the U.S. response, faced criticism in 2024 for his recommendations. This article explores the scientific implications of SARS-CoV-2 transmission and the lessons learned.
Naltrexone, widely recognized for its effectiveness in treating opioid and alcohol addiction, is now available in an innovative form: transdermal patches. This method offers multiple advantages, including better treatment adherence, stable blood levels, and fewer side effects. While research is still ongoing, naltrexone patches could revolutionize addiction treatment, improving patients' quality of life. Discover how this technology could transform the approach to addiction treatment.
Since the Modern Age, creative individuals and entrepreneurs have sought to protect their inventions through patents, gaining legal advantages to capitalize on their ideas. Obtaining a patent grants exclusive rights, competitive advantages, and the possibility of generating income. However, it also presents challenges such as high costs, restrictions on access to new technologies, and potential monopolies. In the pharmaceutical industry, patents are crucial for protecting innovations, but they can also be an obstacle to developing equivalent products. Read all about patents in the industry.
Discover the critical role of the microbiome in neurodegenerative diseases and the challenges facing current research. This blog explores the significance of the gut-brain connection, the bidirectional operation of the Central Nervous System-Gut-Microbiota axis, and the implications for conditions like Parkinson's and Alzheimer's. Despite emerging concerns about research validity, there is substantial evidence supporting the microbiome's involvement in neurological health. Learn about the complexities and future directions for microbiome studies, emphasizing the need for rigorous clinical trials to unlock new therapeutic strategies.
Management Control in a Laboratory: Optimization and Strategic Oversight" discusses the vital role of management control in overseeing pharmaceutical activities. It covers budgeting, performance monitoring, and strategic decision-making to ensure efficiency and goal achievement in a medical laboratory setting.
Ensuring adhesion throughout the use of a medicinal patch is crucial for providing safe and reliable products. Discover how an adhesive overlay can be the solution to adhesion problems and the challenges its formulation presents. From compatibility with the active ingredient to the ideal size and the ability to avoid interfering with drug release, delve into the complex technical aspects that make medicinal patches effective.
Transdermal patches provide a non-invasive, efficient method for drug delivery with better bioavailability and consistent administration, ideal for long-term treatments while reducing gastrointestinal side effects. Read more to learn about proper handling and correct usage.
Advances in ethical alternatives to animal experimentation, such as in vitro models and the implementation of the "3R" principle, show a growing commitment to animal welfare, improving research quality, and protecting the environment. These practices offer more relevant results for humans while addressing ethical and scientific concerns. Integrating humane and effective methods like cell models, toxicogenomics, and computational models promotes more ethical, accurate, and sustainable research.
Transdermal patches, those discreet allies we adhere to our skin to release drugs in a controlled manner, have come a long way since their introduction in 1979. While they have multiple advantages, they have not reached the market massively due to the significant challenges that a molecule must overcome to be administered by this route. To highlight this minority participation within the array of means to administer drugs to the body, we can mention that between 2015 and 2022, only 84 transdermal patches were approved out of a total of 7239 generic products by the FDA, representing just 1.2% of these products.
In the 17th century, scientific work was disseminated through prestigious entities like academies or universities. Manuscripts were reviewed and published based on the institution members' judgment. This method persisted until the 20th century when commercial publishers led to the emergence of Peer Review and the Journal Impact Factor (JIF). Open Access, which advocates for free access to scientific information, also became important. Despite facilitating scientific communication, these factors also led to problems like plagiarism and data fabrication.
Subscribe to
#AmarinNews
Partner with us!
We offer expertise and experience, together with flexibility and the ability to adapt to your needs.
- info@amarintech.com.ar
- +54 11 4588-6500
- Sanchez 2045 (C1416BQG), Buenos Aires, Argentina.
